Please use this identifier to cite or link to this item: https://scidar.kg.ac.rs/handle/123456789/9950
Title: Effects of tibolone on bone mass in postmenopausal women
Authors: Krejovic S.
Zivanovic, Aleksandar
Hasani B.
Ille T.
Glisic A.
Journal: Turkish Journal of Rheumatology
Issue Date: 1-Jan-2011
Abstract: Objectives: We aimed to investigate the effects and tolerability of tibolone treatment in women with postmenopausal osteoporosis. Patients and methods: Patients received tibolone tablets orally once a day after receiving strict instructions. All patients received calcium supplementation with 500 mg of active calcium, and 400 IU of vitamin D. For the purpose of this study, 93 women who received tibolone for two years were examined. They comprised the study group. The second group included 33 women with osteoporosis who received only a supplement of 500 mg of active calcium and 400 IU vitamin D. The third group (control) was composed of 42 women with osteoporosis who took no medication if advised to do so. Bone mineral density was measured at the lumbar spine, and measurements were performed prior to treatment, after one year, and after two years of treatment using the dual energy X-ray absorptiometry method. The bone mineral density was examined in the group of 33 women taking calcium and vitamin D and in the group taking no medication. Results: A 4.9% improvement in bone mass was registered after a year of treatment with tibolone, and there was a 7.5% improvement after two years. In patients receiving calcium and vitamin D, a significant increase in bone mass of 2.9% occurred as well after a year, but the values returned to the baseline level after the second year. In patients without any treatment, the bone mass decreased by 0.6% after a year and by 0.9% after the second year. Conclusion: Our two-year study of the efficacy and tolerability of tibolone in women with osteoporosis confirmed that tibolone significantly increases vertebral bone mass with good tolerability. This finding indirectly implies that the risk of both vertebral and non-vertebral fractures is also significantly reduced. © 2011 Turkish League Against Rheumatism. All rights reserved.
URI: https://scidar.kg.ac.rs/handle/123456789/9950
Type: article
DOI: 10.5152/tjr.2011.035
ISSN: 13090291
SCOPUS: 80053281005
Appears in Collections:Faculty of Medical Sciences, Kragujevac

Page views(s)

43

Downloads(s)

1

Files in This Item:
File Description SizeFormat 
PaperMissing.pdf
  Restricted Access
29.86 kBAdobe PDFThumbnail
View/Open


Items in SCIDAR are protected by copyright, with all rights reserved, unless otherwise indicated.